Anzahl der Einträge: 4.
2021
van den Bent, Martin J.,
Tesileanu, C. Mircea S. ![ORCID 0000-0003-3541-9242](/images/orcid_16x16.gif)
,
Wick, Wolfgang,
Sanson, Marc,
Brandes, Alba Ariela,
Clement, Paul M.,
Erridge, Sarah,
Vogelbaum, Michael A.,
Nowak, Anna K. ![ORCID 0000-0002-9317-9526](/images/orcid_16x16.gif)
,
Baurain, Jean Français,
Mason, Warren P.,
Wheeler, Helen,
Chinot, Olivier L.,
Gill, Sanjeev,
Griffin, Matthew,
Rogers, Leland,
Taal, Walter ![ORCID 0000-0002-5530-7259](/images/orcid_16x16.gif)
,
Rudà, Roberta,
Weller, Michael,
McBain, Catherine,
Reijneveld, Jaap,
Enting, Roelien H.,
Caparrotti, Francesca,
Lesimple, Thierry,
Clenton, Susan,
Gijtenbeek, Anja,
Lim, Elizabeth,
Herrlinger, Ulrich,
Hau, Peter,
Dhermain, Frederic,
de Heer, Iris,
Aldape, Kenneth,
Jenkins, Robert B.,
Dubbink, Hendrikus Jan,
Kros, Johan M.,
Wesseling, Pieter,
Nuyens, Sarah,
Golfinopoulos, Vassilis,
Gorlia, Thierry,
French, Pim und
Baumert, Brigitta G.
(2021)
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
The Lancet Oncology 22 (6), S. 813-823.
Volltext nicht vorhanden.
2017
van den Bent, Martin J.,
Baumert, Brigitta,
Erridge, Sara C.,
Vogelbaum, Michael A.,
Nowak, Anna K. ![ORCID 0000-0002-9317-9526](/images/orcid_16x16.gif)
,
Sanson, Marc,
Brandes, Alba Ariela,
Clement, Paul M.,
Baurain, Jean Francais,
Mason, Warren P.,
Wheeler, Helen,
Chinot, Olivier L.,
Gill, Sanjeev,
Griffin, Matthew,
Brachman, David G.,
Taal, Walter,
Rudà, Roberta,
Weller, Michael,
McBain, Catherine,
Reijneveld, Jaap,
Enting, Roelien H.,
Weber, Damien C.,
Lesimple, Thierry,
Clenton, Susan,
Gijtenbeek, Anja,
Pascoe, Sarah,
Herrlinger, Ulrich,
Hau, Peter,
Dhermain, Frederic,
van Heuvel, Irene,
Stupp, Roger,
Aldape, Ken,
Jenkins, Robert B.,
Dubbink, Hendrikus Jan,
Dinjens, Winand N. M.,
Wesseling, Pieter ![ORCID 0000-0001-5453-5201](/images/orcid_16x16.gif)
,
Nuyens, Sarah,
Golfinopoulos, Vassilis,
Gorlia, Thierry,
Wick, Wolfgang und
Kros, Johan M.
(2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
The Lancet 390 (10103), S. 1645-1653.
Volltext nicht vorhanden.
2010
2009
Stupp, Roger,
Hegi, Monika E.,
Mason, Warren P.,
van den Bent, Martin J.,
Taphoorn, Martin J. B.,
Janzer, Robert C.,
Ludwin, Samuel K.,
Allgeier, Anouk,
Fisher, Barbara,
Belanger, Karl,
Hau, Peter,
Brandes, Alba A.,
Gijtenbeek, Johanna,
Marosi, Christine,
Vecht, Charles J.,
Mokhtari, Karima,
Wesseling, Pieter,
Villa, Salvador,
Eisenhauer, Elizabeth,
Gorlia, Thierry,
Weller, Michael,
Lacombe, Denis,
Cairncross, J. Gregory und
Mirimanoff, René-Olivier
(2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
The lancet oncology 10 (5), S. 459-466.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Tue Jul 16 23:47:35 2024 CEST.